<DOC>
	<DOCNO>NCT01848327</DOCNO>
	<brief_summary>Background/Rationale : Cognitive problem common symptom individual Multiple Sclerosis ( MS ) . Treatment option limit , press need new intervention treat MS-related cognitive impairment . Glucose ( type sugar ) use fuel cell healthy brain . For people neurological condition MS , glucose convert energy efficiently would healthy brain , lead decrease cognitive function . Caprylic Triglyceride may work bypass problem provide alternative energy source metabolize liver use brain . Objective : To evaluate therapeutic effect 90 day caprylic triglyceride cognitive impairment multiple sclerosis . Design : Randomized , double blind , placebo control trial 158 subject . Outcome : Change Total Learning ( Trials 1-5 ) California Verbal Learning Test-2nd Edition- ( CVLT-II ) AND Change Symbol Digit Modalities Test ( SDMT ) ( day 90</brief_summary>
	<brief_title>Caprylic Triglyceride Treatment Cognitive Impairments Multiple Sclerosis</brief_title>
	<detailed_description>Patients type MS ( Relapsing Remitting , Secondary Progressive , Primary Progressive ) eligible participate . Participants undergo detailed cognitive assessment initiate treatment 90 day treatment , determine whether Caprylic Triglyceride demonstrate benefit placebo . Dosage : 40 gram packet orally day Duration Treatment : 90 day Analyses : Interim analyse conduct 72 subject complete trial objective STOP criterion efficacy futility define protocol . Final analysis intent-to-treat ( ITT ) analysis evaluate primary aim .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Cognition Disorders</mesh_term>
	<criteria>1 . Institutional Review Board ( IRB ) approve Informed Consent Form sign patient 2 . A diagnosis MS define Revised McDonald criterion . 3 . All subtypes MS , relapse progressive , eligible . 4 . Males females age 18 59 year old . 5 . Complaints difficulty memory aspect cognition . 6 . MiniMental Status Exam ( MMSE ) score &gt; =24 determination ability provide inform consent . 7 . 8th grade English reading proficiency determine Wide Range Achievement Test4th editionreading . 8 . Females childbearing potential must negative pregnancy test prior entry treatment phase must simultaneously use two form effective contraception treatment one month one menstrual cycle discontinuation study medication . 9 . All concomitant medication dos must stable least 30 day prior randomization remain stable study duration . 10 . An Expanded Disability Status Scale ( EDSS ) score least 2.0 Functional System Score least 2 Cerebral section due decrease mentation . 11 . Stable neurologic function multiple sclerosis relapse least 30 day prior study entry . 12 . No clinically significant abnormal finding physical examination , medical history , clinical laboratory result Screen . 13 . Documented memory deficit define score least 0.5 standard deviation ( SD ) age genderbased normative value Total Learning Score CVLTII OR document process speed deficit define score least 1.0 SD normative value SDMT . 1 . Any condition would render patient caregiver unsuitable study , place substantial risk adverse outcome . 2 . Unwillingness/inability patient fulfill study requirement . 3 . Evidence major depression score BDIII &gt; = 30 OR score &lt; 30 BDIII endorse suicidal ideation . 4 . Hypothyroidism 5 . B12 deficiency 6 . Diabetes ( Type 1 2 ) . 7 . Positive rapid plasma reagin . 8 . Fasting triglyceride level &gt; 2 time upper limit normal value w/in 3 month Study Visit 1 . 9 . History malignancy organ system ( localize squamous basal cell carcinoma skin ) , treat untreated , within past 2 year . 10 . Clinically significant renal disease insufficiency . 11 . Clinically significant hepatic disease insufficiency . 12 . Ethanol consumption great equivalent 2 oz/20 g/2 unit spirit per day OR 14 oz/140 g/14 unit spirit per week . One oz/10 g/1 unit spirit = 6 oz/15 g/1 unit wine = 12 oz/12 g/1 unit beer . 13 . History current alcohol substance abuse . 14 . Known HIV infection . 15 . History head injury loss consciousness &gt; 30 minute . 16 . History inflammatory bowel syndrome . 17 . History severe irritable bowel disease . 18 . History severe gastroesophageal reflux disease . 19 . History diverticular disease . 20 . Use investigational compound within 30 day prior screen . 21 . Prior current use medium chain triglycerides medical purpose . 22 . Known allergy dairy product soy . 23 . Use anticholinergic medication within 30 day prior Study Visit 1 . 24 . Use acetylcholinesterase inhibitor within 30 day prior Study Visit 1 . 25 . Use memantine within 30 day prior Study Visit 1 . 26 . Use stimulant within 30 day prior Study Visit 1 27 . Use modafinil , amantadine , dalfampridine within 30 day prior Study Visit 1 , unless dose stable 90 day prior Study Visit 1 28 . Use orlistat within 30 day prior Study Visit 1 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>59 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Cognition</keyword>
	<keyword>Neuropsychology</keyword>
	<keyword>Multiple Sclerosis</keyword>
</DOC>